Role of Indoleamine-2,3-Dioxygenase in Alpha/Beta and Gamma Interferon-Mediated Antiviral Effects against Herpes Simplex Virus Infections

Journal of Virology

Volumn 78, Issue 5, 2004, Pages 2632-2636

  Adams, O ^a   Besken, K ^a   Oberdorfer C ^a   MacKenzie, C R ^a   Takikawa, O ^b   Daubener W ^a,c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b HOKKAIDO UNIVERSITY   (Japan)

^c Institute for Medical Microbiology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERFERON; MESSENGER RNA; TRYPTOPHAN;

ANTIVIRAL ACTIVITY; ARTICLE; ASTROCYTOMA CELL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HOST RESISTANCE; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS ENCEPHALITIS; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; ASTROCYTOMA; CELL LINE, TUMOR; ENZYME INDUCTION; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERONS; RNA, MESSENGER; SIMPLEXVIRUS; TRYPTOPHAN; TRYPTOPHAN OXYGENASE; VIRUS REPLICATION;

EID: 1242319376     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.5.2632-2636.2004     Document Type: Article

References (44)

1. Becker, Y. 2002. Herpes simplex virus evolved to use the human defense mechanisms to establish a lifelong infection in neurons - a review and hypothesis. Virus Genes 24:187-196.
2. Bilzer, T., D. Stavrou, E. Dahme, E. Keiditsch, K. F. Burrig, A. P. Anzil, and W. Wechsler. 1991. Morphological, immunocytochemical and growth characteristics of three human glioblastomas established in vitro. Virchows Arch. A Pathol. Anat. Histopathol. 418:281-293.
3. Bodaghi, B., O. Goureau, D. Zipeto, L. Laurent, J. L. Virelizier, and S. Michelson. 1999. Role of IFN-gamma-induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells. J. Immunol. 162:957-964.
4. Bogdan, C., M. Rollinghoff, and A. Diefenbach. 2000. The role of nitric oxide in innate immunity. Immunol. Rev. 173:17-26.
5. Bukrinsky, M., H. Schmidtmayerova, G. Zybarth, L. Dubrovsky, B. Sherry, and G. Enikolopov. 1996. A critical role of nitric oxide in human immunodeficiency virus type 1-induced hyperresponsiveness of cultured monocytes. Mol. Med. 2:460-468.
6. Byrne, G. I., L. K. Lehmann, J. G. Kirschbaum, E. C. Borden, C. M. Lee, and R. R. Brown. 1986. Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity. J. Interferon Res. 6:389-396.
7. Byrne, G. I., L. K. Lehmann, and G. J. Landry. 1986. Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect. Immun. 53:347-351.
8. s11 protein interacts with protein kinase R in infected cells and requires a 30-amino-acid sequence adjacent to a kinase substrate domain. J. Virol. 76:2029-2035.
9. Däubener, W., K. Pilz, Z. S. Seghrouchni, T. Bilzer, H. G. Fischer, and U. Hadding. 1993. Induction of toxoplasmostasis in a human glioblastoma by interferon gamma. J. Neuroimmunol. 43:31-38.
10. Däubener, W., V. Posdziech, U. Hadding, and C. R. MacKenzie. 1999. Inducible anti-parasitic effector mechanisms in human uroepithelial cells: tryptophan degradation vs. NO production. Med. Microbiol. Immunol. (Berlin) 187:143-147.
11. Däubener, W., B. Spors, C. Hucke, R. Adam, M. Stins, K. S. Kim, and H. Schroten. 2001. Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase. Infect. Immun. 69:6527-6531.
12. Däubener, W., N. Wanagat, K. Pilz, S. Seghrouchni, H. G. Fischer, and U. Hadding. 1994. A new, simple, bioassay for human IFN-gamma. J. Immunol. Methods 168:39-47.
13. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2412.
14. Ellison, A. R., L. Yang, C. Voytek, and T. P. Margolis. 2000. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains. Virology 268:17-28.
15. Ghosh, S. K., J. Kusari, S. K. Bandyopadhyay, H. Samanta, R. Kumar, and G. C. Sen. 1991. Cloning, sequencing, and expression of two murine 2′-5′-oligoadenylate synthetases. Structure-function relationships. J. Biol. Chem. 266:15293-15299.
16. Guidotti, L. G., H. McClary, J. M. Loudis, and F. V. Chisari. 2000. Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice. J. Exp. Med. 191:1247-1252.
17. Hermann, E., T. Idziorek, J. P. Kusnierz, Y. Mouton, A. Capron, and G. M. Bahr. 1997. Role of nitric oxide in the regulation of lymphocyte apoptosis and HIV-1 replication. Int. J. Immunopharmacol. 19:387-397.
18. Heyes, M. P., B. J. Brew, K. Saito, B. J. Quearry, R. W. Price, K. Lee, R. B. Bhalla, M. Der, and S. P. Markey. 2003. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients. J. Neuroimmunol. 40:71-80.
19. Huang, T., J. Pavlovic, P. Staeheli, and M. Krystal. 1992. Overexpression of the influenza virus polymerase can titrate out inhibition by the murine Mx1 protein. J. Virol. 66:4154-4160.
20. Hwu, P., M. X. Du, R. Lapointe, M. Do, M. W. Taylor, and H. A. Young. 2000. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J. Immunol. 164:3596-3599.
21. Karupiah, G., J. H. Chen, S. Mahalingam, C. F. Nathan, and J. D. MacMicking. 1998. Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice. J. Exp. Med. 188:1541-1546.
22. Katze, M. G. 1995. Regulation of the interferon-induced PKR: can viruses cope? Trends Microbiol. 3:75-78.
23. Katze, M. G., Y. He, and M. Gale, Jr. 2002. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2:675-687.
24. Kleinschmidt-DeMasters, B. K., and D. H. Gilden. 2001. The expanding spectrum of herpesvirus infections of the nervous system. Brain Pathol. 11:440-451.
25. Liebau, P., E. Kuse, M. Winkler, H. J. Schlitt, K. Oldhafer, W. Verhagen, J. Flik, and R. Pichlmayr. 1996. Management of herpes simplex virus type 1 pneumonia following liver transplantation. Infection 24:130-135.
26. Ljungman, P. 1993. Herpes virus infections in immunocompromised patients: problems and therapeutic interventions. Ann. Med. 25:329-333.
27. MacKenzie, C. R., U. Hadding, and W. Däubener. 1998. Interferon-gamma-induced activation of indoleamine 2,3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci. J. Infect. Dis. 178:875-878.
28. MacLean, A., X. Q. Wei, F. P. Huang, U. A. Al Alem, W. L. Chan, and F. Y. Liew. 1998. Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses. J. Gen. Virol. 79(Pt. 4):825-830.
29. Munn, D. H., E. Shafizadeh, J. T. Attwood, I. Bondarev, A. Pashine, and A. L. Mellor. 1999. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189:1363-1372.
30. Munn, D. H., M. Zhou, J. T. Attwood, I. Bondarev, S. J. Conway, B. Marshall, C. Brown, and A. L. Mellor. 1998. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191-1193.
31. Naik, H. R., and P. H. Chandrasekar. 1996. Herpes simplex virus (HSV) colitis in a bone marrow transplant recipient. Bone Marrow Transplant. 17:285-286.
32. Nicholl, M. J., L. H. Robinson, and C. M. Preston. 2000. Activation of cellular interferon-responsive genes after infection of human cells with herpes simplex virus type 1. J. Gen. Virol. 81:2215-2218.
33. Pfefferkorn, E. R. 1984. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. USA 81:908-912.
34. Rinaldo, C. R., Jr., and D. J. Torpey III. 1993. Cell-mediated immunity and immunosuppression in herpes simplex virus infection. Immunodeficiency 5:33-90.
35. Roubalova, K., A. Suchankova, A. Vitek, and J. Sajdova. 2000. Presence of herpes simplex virus (HSV) in peripheral leukocytes of patient who developed active HSV infection after bone marrow transplantation. J. Clin. Virol. 17:37-42.
36. Samuel, C. E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:778-809.
37. Schibli, D. J., R. C. Montelaro, and H. J. Vogel. 2001. The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles. Biochemistry 40:9570-9578.
38. Schmitz, J. L., J. M. Carlin, E. C. Borden, and G. I. Byrne. 1989. Beta interferon inhibits Toxoplasma gondii growth in human monocyte-derived macrophages. Infect. Immun. 57:3254-3256.
39. Schroten, H., B. Spors, C. Hucke, M. Stins, K. S. Kim, R. Adam, and W. Daubener. 2001. Potential role of human brain microvascular endothelial cells in the pathogenesis of brain abscess: inhibition of Staphylococcus aureus by activation of indoleamine 2,3-dioxygenase. Neuropediatrics 32:206-210.
40. Terness, P., T. M. Bauer, L. Rose, C. Dufter, A. Watzlik, H. Simon, and G. Opelz. 2002. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196:447-457.
41. van Wissen, M., M. Snoek, B. Smids, H. M. Jansen, and R. Lutter. 2002. IFN-gamma amplifies IL-6 and IL-8 responses by airway epithelial-like cells via indoleamine 2,3-dioxygenase. J. Immunol. 169:7039-7044.
42. Whitley, R. 1981. Diagnosis and treatment of herpes simplex encephalitis. Annu. Rev. Med. 32:335-340.
43. Whitley, R. J., and B. Roizman. 2001. Herpes simplex virus infections. Lancet 357:1513-1518.
44. Wingard, J. R. 1993. Viral infections in leukemia and bone marrow transplant patients. Leuk. Lymphoma 11(Suppl. 2):115-125.